An insertion sequence-like element, IS6110, was isolated from a Mycobacterium tuberculosis cosmid library as a repetitive sequence. IS6110 shows similarities with elements of the IS3 family. This insertion sequence was found to be specific to mycobacteria belonging to the M. tuberculosis complex. For detection and identification of M. tuberculosis bacilli in uncultured specimens, oligonucleotides derived from the IS6110 sequence were used as primers and probes in polymerase chain reaction studies. The results obtained were consistent with results of classical identification procedures, bacteriological data, and clinical criteria.
hybridization of 1251I-labeled DNA fragments corresponding to 16S RNA sequences, have been described previously. Although these techniques reduce the identification time, they still require at least a 1-week culturing period.
The technique of in vitro amplification of specific DNA sequences is a sensitive method for the detection of viruses and bacteria in pathological samples (10, 16, 20) . We have recently adapted this technique to the detection and identification of mycobacteria in uncultured clinical specimens (3, 12) by making use of polymorphism in the gene coding for the 65-kDa heat shock protein in bacteria.
In several cases it has been shown that repetitive DNA sequences display species specificity. For example, the insertion sequence IS900 was shown to be specific to Mycobacterium paratuberculosis (9) . In this report, we describe the identification of a repetitive sequence from Mycobacterium tuberculosis. This element, IS6110, possesses similarities to insertion sequences of the IS3 family (15, 19, 22) . IS6110 is 1,361 bp long and contains 28-bp, imperfect inverted repeats at its extremities with three mismatches and 3-bp direct repeats that probably result from repetition of the target sequence. Among the various mycobacterial species examined, IS6110 was detected only in species belonging to the M. tuberculosis complex. Oligonucleotides derived from this sequence were used to detect M. tuberculosis in clinical specimens following in vitro DNA amplification. MATERIALS (ii) DNA preparation. For amplification experiments, mycobacteria from 1-ml cultures were pelleted, resuspended in 200 ,uI of lysis buffer (0.1 M NaOH, 2M NaCl, 0.5% SDS), and incubated at 95°C for 15 min. DNAs from the resulting lysates were extracted twice with phenol-chloroform, precipitated with ethanol, and resuspended in 100 ,ul of sterile water.
DNA was extracted from 0.2 to 1 ml of crude or sodium hydroxide-decontaminated clinical specimens by the same procedure described above. Ten-microliter aliquots were used for amplification.
(iii) DNA amplification. Amplification reactions were performed in a total volume of 100 ,ul in 10 mM Tris hydrochloride (pH 8.3)-1.5 mM MgCl2-50 mM KCl-12.5 pmol of each primer-125 ,uM (each) deoxynucleoside triphosphates (dATP, dGTP, dTTP, and dCTP)-2 U of Thermus aquaticus DNA polymerase (Perkin Elmer Corp., Norwalk, Conn.). The amplification mixture was overlaid with 50 ,ul of mineral ou and subjected to 40 cycles of amplification as follows. Samples were incubated for 2 min at 94°C to denature the DNA, for 2 min at 60°C to anneal the primers, and for 2 min at 72°C to extend the annealed primers. Thermal cycling was performed in a programmable heat block (Perkin Elmer). Samples were then electrophoresed through a 1.5% agarose gel; amplification products were visualized by ethidium bromide staining.
(iv) Hybridization with labeled oligonucleotides. Amplified DNAs were resolved on agarose gels and transferred onto Hybond N nylon filters (Amersham) by Southern blotting (17) . After a 15-min prehybridization in Rapid Hybridization Buffer (Amersham) at 65°C, membranes were hybridized with 106 cpm of 32P-labeled probe in the same buffer for at least 2 h at 65°C. Filters were then washed twice in 2 x SSC-0. 1% SDS at 200C for 10 Fig. 1 ). This fragment was purified and cloned in phages M13mpl8 and M13mpl9. The nucleotide sequences of this fragment and its adjacent regions were determined and shown to be similar to insertion sequences of the IS3 family. The complete nucleotide sequence of this insertion sequence-like element IS6110 has been described previously (21 (Fig. 3) . Preliminary experiments with pulsed-field electrophoresis followed by Southern blotting showed that IS6110 sequences are scattered throughout the M. tuberculosis chromosome (data not shown). A search for the presence of IS6110 in M. tuberculosis strains isolated from various patients revealed a different arrangement of these elements in the genomes of these strains (6) . These (Fig. 4) , and for the 11 clinical M. tuberculosis strains (data not shown). In contrast, DNAs from all other mycobacterial species were amplified with TB1 and TB2 but not with ISTB2 and ISTB7 (Fig. 4) probe. The amplification specificity was further verified by using DNA from other bacterial species, i.e., Staphylococcus aureus, E. coli, Micromonospora chalcea, Nocardia asteroides, and several streptomycetes (S. lividans, S. hygroscopicus, S. viridochromogenes, S. antibioticus, and S. fradiae). None of these species was amplified with the ISTB2 and ISTB7 set of primers (data not shown).
In order to test the sensitivity of in vitro amplification of mycobacterial DNA with ISTB2 and ISTB7 and TB1 and TB2 primers, different concentrations of M. tuberculosis DNA (10 ng to 1 fg) were amplified. The results presented in Fig. 5 show that the ISTB2 and ISTB7 primers enable detection of less than 10 fg of DNA. This DNA amount corresponds to about three genome equivalents (one genome being approximately 2.5 x 109 Da mol-'). For the lowest DNA amounts, the signals obtained with ISTB2 and ISTB7 were stronger than those obtained with TB1 and TB2. In fact, amplification with ISTB2 and ISTB7 primers allowed detection of DNA from mycobacteria at a 10-fold-lower level than amplification with TB1 and TB2 did. This result is in agreement with the presence of 10 to 20 copies of IS6110 in the M. tuberculosis genome. The gene coding for the 65-kDa protein was believed to be present as a single copy, while more recent studies with E. coli strains have suggested the presence of another gene similar to groEL encoding the 65-kDa heat shock protein (11) . An IS6110-derived PCR appears to be more specific, since both amplification and hybridization are specific for bacilli of the M. tuberculosis complex, whereas the 65-kDa-based PCR uses nonspecific primers for amplification followed by hybridization with specific probes. Another PCR based on IS6110 has also been described by Eisenach and colleagues (5, 21) , who obtained comparable results with different primers.
Detection of M. tuberculosis strains in uncultured clinical specimens. In vitro amplification with IS6110 and the 65-kDa antigen-derived oligonucleotides used as primers and probes was applied to the detection of M. tuberculosis in 75 clinical specimens, including 42 gastric aspirate, 17 sputum, 6 cerebrospinal fluid, 2 serum, 3 cystotomy, 4 pleural liquid, and 1 urine specimen. These specimens were tested in parallel by classical bacteriological methods, direct microscopic examination after Ziehl-Neelsen staining, and culture on Loewenstein-Jensen medium. Total DNA from 0.2 to 1 ml of each sample was extracted and resuspended in 100 ,ul of water.
Aliquots (10 pl) were amplified with the ISTB2 and ISTB7 primers, and the amplification products were analyzed by Southern blot hybridization by using IS-2 as a probe. The results obtained with several samples are shown in Fig. 6 . Conclusions obtained by PCR analyses were based on results obtained from two or three independent experiments.
Results obtained by PCRs were consistent with bacteriological data and clinical criteria. All samples positive by direct examination and/or culture gave a positive result by DNA amplification (Table 1) . Among 45 samples found negative by bacteriological analysis, 5 were positive by PCRs. These samples were not likely to represent falsepositive results, since they were from patients in whom tuberculosis was highly suspected or already diagnosed. Three independent cystotomy specimens were from a patient for whom renal tuberculosis was diagnosed on the basis of positive culture results obtained with other specimens (ureteral samples). Two pleural liquid specimens came from a patient for whom tuberculosis was highly suspected and whose general state greatly improved under anti-tuberculous treatment. The presence of M. tuberculosis bacilli was also detected in two serum specimens, which were not tested by culture, from patients with tuberculous meningitis and for whom cerebrospinal fluids were found to be positive both by culture and by PCRs. On the other hand, analysis of samples known to contain M. avium bacilli by bacteriological analysis were found to be negative by amplification with ISTB2 and ISTB7 primers derived from the IS6110 sequence.
Two samples found to be positive by direct examination were initially found to be negative by PCR methods. To test the efficiency of DNA amplification in these samples, 10 ng of pUC19 (26) corresponding to plasmid DNA and primers allowing the amplification of a 517-bp internal fragment of this plasmid (a part of the bla gene, which is responsible for ampicillin resistance) was added to the reaction. No amplification of the 517-bp fragment was observed when 10 ,u of the sample mixture was added in the amplification reaction. However, amplification for both pUC19 and IS6110 sequences was obtained when 10-fold dilution of the sample preparation was added (Fig. 7) . This result demonstrates that some samples may occasionally contain inhibitors of the amplification reaction. Consequently, all specimens should be systematically tested for their amplification capability.
The results presented here indicate that greatly improved tuberculosis diagnosis is possible by the PCR technique, which is more rapid and more sensitive than classical bacteriological techniques. The PCR might be especially useful in patients for whom no presumptive diagnosis is available, such as for disseminated forms of tuberculosis that are frequently encountered in patients with acquired immune deficiency syndrome (23, 25) .
Technical improvements of the method, including the use of nonradioactive probes and hybridization format, are being investigated to simplify the technique for routine use in clinical laboratories.
